Investor Lawsuit Against Acquisition of Hospira, Inc. (HSP) Announced by Shareholders Foundation

SAN DIEGO, Feb. 17, 2015 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that an investor, who currently holds shares of Hospira, Inc. HSP, filed a lawsuit in effort to stop the proposed takeover of Hospira, Inc. by Pfizer for $90 per share.

Investors, who purchased shares of Hospira, Inc. HSP prior to February 5, 2015, and currently hold any of those HSP shares, have certain options and should contact the Shareholders Foundation, Inc. at mail@shareholdersfoundation.com or call +1 (858) 779 - 1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to HSP stockholders by agreeing to sell Hospira, Inc. too cheaply via an unfair process to Pfizer Inc.

On February 5, 2015, Pfizer Inc. and Hospira, Inc. HSP announced that they have entered into a merger agreement under which Pfizer will acquire Hospira for $90 a share in cash for a total enterprise value of approximately $17 billion.

However, the plaintiff claims that the $90-offer is too low and undervalues Hospira, Inc. In addition, the plaintiff claims that the process is also unfair to HSP stockholders.

Those who currently hold Hospira, Inc. HSP shares have certain options and should contact the Shareholders Foundation, Inc. at mail@shareholdersfoundation.com or call +1 (858) 779 - 1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.